Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
femselect.com

See what CB Insights has to offer

Stage

Angel - IV | Alive

Total Raised

$580K

About FEMSelect

Provider of a minimally invasive, meshless, dissectionless solution for the repair of pelvic organ prolapse (POP). The company's solutions use a trans-vaginal approach that aims to be easier and less invasive than traditional methods for the treatment of uterine prolapse. The installation procedure can take up to fifteen minutes.

FEMSelect Headquarter Location

HaMa’ayan 2 First Floor

7177871,

Israel

972 54 945 6260

Latest FEMSelect News

10:35 ET LiNA Medical USA and FEMSelect Announce National Launch of the EnPlace® Pelvic Floor Ligament Fixation System

Aug 10, 2021

News provided by Share this article (PRNewsfoto/FEMSelect,LiNA Medical USA) NORCROSS, Ga., Aug. 10, 2021 /PRNewswire/ -- LiNA Medical USA and FEMSelect today announced the national launch of FEMSelect's EnPlace® pelvic floor ligament fixation system. The EnPlace technology will now be available nationwide via LiNA Medical USA's specialized sales force, on behalf of FEMSelect, the developer of EnPlace. The EnPlace patented delivery system enables the precise guidance, insertion and deployment of a small, nitinol anchor for pelvic floor ligament fixation. The approach is performed with minimal dissection and no mesh. This nationwide launch will now enable access to the technology across the US for both pelvic floor repair surgeons and the applicable patients who have not had this option available previously. "We are pleased to offer the EnPlace system nationwide following months of preparations and productive training meetings for our sales force," said Lars Melbye, President of LiNA Medical USA. "LiNA has been impressed with market feedback in the initial pilot territories and is looking forward to offering the EnPlace system to qualified surgeons across the US who are looking for a system to enable a minimally invasive approach for their apical pelvic organ prolapse patients." "Studies show that nearly 50% of women over the age of 50 have pelvic organ prolapse. In the US, that would equate to 30 million women yet only 3 million women are diagnosed and only 15% of them are treated as there is no minimally invasive option. With the guidance of LiNA's sales team, we look forward to the EnPlace innovation reaching women across the US," said Debbie Garner, Co-CEO of FEMSelect. For more information about the EnPlace system, please contact [email protected] or visit https://femselect.com . About LiNA Medical USA LiNA Medical USA specializes in selling innovative, minimally invasive devices in the fields of gynecology and urology. The company is dedicated to partnering with organizations that offer related products that improve the lives of patients and the healthcare professionals that treat them. For more information, visit: https://linamed.com . About FEMSelect FEMSelect is a women-led company with a mission to make a lasting impact on women's health by delivering innovative technologies that provide consistent results in a patient-centric manner and dramatically improve outcomes for women. For more information, visit: https://femselect.com . SOURCE LiNA Medical USA; FEMSelect Related Links

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing FEMSelect

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FEMSelect is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,401 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

W

Women's Health & Wellness

947 items

Startups focused on providing products and services catering to women's health and wellbeing.

FEMSelect Patents

FEMSelect has filed 4 patents.

The 3 most popular patent topics include:

  • Endoscopy
  • Gynaecology
  • Medical equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/10/2015

8/3/2021

Joints, Gynaecology, Pelvis, Orthopedic surgical procedures, Vagina

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/10/2015

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/3/2021

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Joints, Gynaecology, Pelvis, Orthopedic surgical procedures, Vagina

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.